The exercise of 2.55 million warrants at $1.50 per share indicates a potential influx of capital for Revelation Biosciences, which could be used for growth or operational needs. This is likely to be viewed positively by investors, as it suggests confidence in the company's future prospects. The closing date provides a timeline for when these changes will take effect.